In today’s episode, Matthew Clemente talks about the product and engineering scaling challenges working in the biomedical industry.

Key Takeaways:

Connect with Matthew Clemente at https://www.linkedin.com/in/prspctvs

About today’s guest: 

Matthew Clemente currently serves as the Senior Vice President of Product & Development at Bigfoot Biomedical, responsible for an innovative, emerging portfolio of diabetes care services and technologies transforming existing care models.

Matthew previously served as the Corporate Vice President of Delivery Systems Engineering at Novo Nordisk and as the Senior Director and Chief Technology Officer at Eli Lilly & Company, where he led the development of portfolios of connected drug delivery devices, applications, and algorithms that served as the foundation of both drug manufacturers and connected diabetes ecosystems. Before that, he was the Director of Advanced Drug Delivery Systems at Unilife Corporation. He built and managed an integrated engineering and science organization focused on mechanical, electromechanical, digital, and container closure systems for prefilled, preassembled, wearable drug delivery applications. Before Unilife, Matthew held various roles of increasing responsibility at multiple Johnson & Johnson companies. He primarily served in the new product development of insulin pumps at Animas Corporation for J&J’s Diabetes Care Franchise.

Matthew obtained a Bachelor of Science in Biomedical Engineering from the University of Miami and an MBA in Finance from Villanova University.

________

Thank you so much for checking out this episode of The Tech Trek and if you enjoyed this episode,  please take a minute and leave a quick rating and review on the Apple podcast app!

Want to learn more about us? Head over at https://www.elevano.com

Have questions or want to cover specific topics with our future guests?

Please message me at  https://www.linkedin.com/in/amirbormand (Amir Bormand)